Cancer immunotherapy: harnessing the immune system to battle cancer.


Journal Article (Review)

The recent clinical successes of immune checkpoint blockade and chimeric antigen receptor T cell therapies represent a turning point in cancer immunotherapy. These successes also underscore the importance of understanding basic tumor immunology for successful clinical translation in treating patients with cancer. The Reviews in this Review Series focus on current developments in cancer immunotherapy, highlight recent advances in our understanding of basic aspects of tumor immunology, and suggest how these insights can lead to the development of new immunotherapeutic strategies.

Full Text

Cited Authors

  • Yang, Y

Published Date

  • September 2015

Published In

Volume / Issue

  • 125 / 9

Start / End Page

  • 3335 - 3337

PubMed ID

  • 26325031

Pubmed Central ID

  • 26325031

Electronic International Standard Serial Number (EISSN)

  • 1558-8238

International Standard Serial Number (ISSN)

  • 0021-9738

Digital Object Identifier (DOI)

  • 10.1172/JCI83871


  • eng